{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:28:56Z","timestamp":1791804536407,"version":"4.3.4"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019341","name":"Shenzhen Scientific and Technological Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.phrs.2020.105377","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T11:46:08Z","timestamp":1611143168000},"page":"105377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Triptolide delivery: Nanotechnology-based carrier systems to enhance efficacy and limit toxicity"],"prefix":"10.1016","volume":"165","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8802-4810","authenticated-orcid":false,"given":"Qing","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meimei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1625-8682","authenticated-orcid":false,"given":"Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2020.105377_bib0005","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1021\/ja00775a078","article-title":"Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii","volume":"94","author":"Morris","year":"1972","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.phrs.2020.105377_bib0010","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.phytochem.2006.11.029","article-title":"Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae)","volume":"68","author":"Brinker","year":"2007","journal-title":"Phytochemistry"},{"key":"10.1016\/j.phrs.2020.105377_bib0015","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/PRS.0000000000002770","article-title":"Triptolide reduces the required dose of tacrolimus by attenuating inflammation, enhancing immunosuppression, and increasing donor chimerism in a heterotopic hindlimb transplantation model","volume":"138","author":"Gu","year":"2016","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.phrs.2020.105377_bib0020","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.phrs.2018.11.001","article-title":"Molecular pharmacology of inflammation: medicinal plants as anti-inflammatory agents","volume":"139","author":"Tasneem","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2020.105377_bib0025","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.biopha.2017.04.003","article-title":"Toxicity of triptolide and the molecular mechanisms involved","volume":"90","author":"Xi","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2020.105377_bib0030","article-title":"Preclinical pharmacokinetics of triptolide: a potential antitumor drug","author":"Song","year":"2018","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.phrs.2020.105377_bib0035","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.toxlet.2014.08.017","article-title":"Triptolide-induced oxidative stress involved with Nrf2 contribute to cardiomyocyte apoptosis through mitochondrial dependent pathways","volume":"230","author":"Zhou","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.phrs.2020.105377_bib0040","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201700001","article-title":"Quantitative proteomics and targeted fatty acids analysis reveal the damage of triptolide in liver and kidney","volume":"17","author":"Li","year":"2017","journal-title":"Proteomics"},{"key":"10.1016\/j.phrs.2020.105377_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104752","article-title":"Gut microbiota protects from triptolide-induced hepatotoxicity: key role of propionate and its downstream signalling events","author":"Huang","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2020.105377_bib0050","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ejps.2012.05.012","article-title":"Comparison of toxicokinetic and tissue distribution of triptolide-loaded solid lipid nanoparticles vs free triptolide in rats","volume":"47","author":"Xue","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.phrs.2020.105377_bib0055","doi-asserted-by":"crossref","first-page":"8928","DOI":"10.3390\/molecules20058928","article-title":"Absorption and metabolism characteristics of triptolide as determined by a sensitive and reliable LC-MS\/MS method","volume":"20","author":"Gong","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2020.105377_bib0060","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1248\/bpb.31.592","article-title":"Involvement of mitochondrial pathway in triptolide-induced cytotoxicity in human normal liver L-02 cells","volume":"31","author":"Yao","year":"2008","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.phrs.2020.105377_bib0065","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/anie.201408817","article-title":"Covalent modification of a cysteine residue in the XPB subunit of the general transcription factor TFIIH through single epoxide cleavage of the transcription inhibitor triptolide","volume":"54","author":"He","year":"2015","journal-title":"Angew. Chemie Int. Ed."},{"key":"10.1016\/j.phrs.2020.105377_bib0070","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1158\/1535-7163.MCT-15-0753","article-title":"Triptolide induces cell killing in multidrug-resistant tumor cells via CDK7\/RPB1 rather than XPB or p44","volume":"15","author":"Yi","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.phrs.2020.105377_bib0075","first-page":"1191","article-title":"Inhibition effect of triptolide on human epithelial ovarian cancer via adjusting cellular immunity and angiogenesis","volume":"39","author":"Hu","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.phrs.2020.105377_bib0080","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.intimp.2011.01.012","article-title":"Triptolide and its expanding multiple pharmacological functions","volume":"11","author":"Liu","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phrs.2020.105377_bib0085","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nchembio.522","article-title":"XPB, a subunit of TFIIH, is a target of the natural product triptolide","volume":"7","author":"Titov","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.phrs.2020.105377_bib0090","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.canlet.2012.01.006","article-title":"Synergistic anticancer activity of triptolide combined with cisplatin enhances apoptosis in gastric cancer in vitro and in vivo","volume":"319","author":"Li","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2020.105377_bib0095","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.7314\/APJCP.2013.14.7.4267","article-title":"Combined effects of curcumin and triptolide on an ovarian cancer cell line","volume":"14","author":"Cai","year":"2013","journal-title":"Asian Pacific J. Cancer Prev."},{"key":"10.1016\/j.phrs.2020.105377_bib0100","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.surg.2014.04.055","article-title":"Sorafenib and triptolide as combination therapy for hepatocellular carcinoma","volume":"156","author":"Alsaied","year":"2014","journal-title":"Surgery"},{"key":"10.1016\/j.phrs.2020.105377_bib0105","doi-asserted-by":"crossref","first-page":"e948","DOI":"10.1038\/cddis.2013.467","article-title":"Low-dose triptolide in combination with idarubicin induces apoptosis in AML leukemic stem-like KG1a cell line by modulation of the intrinsic and extrinsic factors","volume":"4","author":"Liu","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2020.105377_bib0110","first-page":"2666","article-title":"Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells","volume":"8","author":"Kiviharju","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phrs.2020.105377_bib0115","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.tips.2019.03.002","article-title":"Triptolide and its derivatives as cancer therapies","volume":"40","author":"Noel","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.phrs.2020.105377_bib0120","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0169-409X(00)00103-4","article-title":"Microemulsion-based media as novel drug delivery systems","volume":"45","author":"Lawrence","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.phrs.2020.105377_bib0125","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.addr.2003.12.002","article-title":"Solid lipid nanoparticles for parenteral drug delivery","volume":"56","author":"Wissing","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.phrs.2020.105377_bib0130","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.addr.2006.09.009","article-title":"Multifunctional nanocarriers","volume":"58","author":"Torchilin","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.phrs.2020.105377_bib0135","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1039\/c2cs15344k","article-title":"Targeted polymeric therapeutic nanoparticles: design, development and clinical translation","volume":"41","author":"Kamaly","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.phrs.2020.105377_bib0140","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1039\/c2np00088a","article-title":"Triptolide: structural modifications, structure\u2013activity relationships, bioactivities, clinical development and mechanisms","volume":"29","author":"Zhou","year":"2012","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.phrs.2020.105377_bib0145","first-page":"551","article-title":"Triptolide induces apoptosis in human adrenal cancer NCI-H295 cells through a mitochondrial-dependent pathway","volume":"25","author":"Wu","year":"2011","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.phrs.2020.105377_bib0150","doi-asserted-by":"crossref","DOI":"10.1124\/dmd.113.054056","article-title":"Assessment of the roles of P-glycoprotein and cytochrome P450 in triptolide-induced liver toxicity in sandwich-cultured rat hepatocyte model","author":"Zhuang","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.phrs.2020.105377_bib0155","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery\u2013a review of the state of the art","volume":"50","author":"M\u00fcller","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.phrs.2020.105377_bib0160","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.msec.2016.05.119","article-title":"Solid lipid nanoparticles as attractive drug vehicles: composition, properties and therapeutic strategies","volume":"68","author":"Geszke-Moritz","year":"2016","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.phrs.2020.105377_bib0165","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0939-6411(03)00067-5","article-title":"Solid lipid nanoparticle and microemulsion for topical delivery of triptolide","volume":"56","author":"Mei","year":"2003","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.phrs.2020.105377_bib0170","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.phrs.2004.10.007","article-title":"The research on the anti-inflammatory activity and hepatotoxicity of triptolide-loaded solid lipid nanoparticle","volume":"51","author":"Mei","year":"2005","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2020.105377_bib0175","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1081\/DDC-200047791","article-title":"Triptolide loaded solid lipid nanoparticle hydrogel for topical application","volume":"31","author":"Mei","year":"2005","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.phrs.2020.105377_bib0180","first-page":"673","article-title":"Male reproductive toxicity and toxicokinetics of triptolide in rats","volume":"58","author":"Ni","year":"2008","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.phrs.2020.105377_bib0185","series-title":"Tilte","author":"Zheng","year":"2016"},{"key":"10.1016\/j.phrs.2020.105377_bib0190","doi-asserted-by":"crossref","first-page":"13340","DOI":"10.3390\/molecules181113340","article-title":"Preparation and optimization of triptolide-loaded solid lipid nanoparticles for oral delivery with reduced gastric irritation","volume":"18","author":"Zhang","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2020.105377_bib0195","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1248\/bpb.30.702","article-title":"Pharmacokinetic study of triptolide, a constituent of immunosuppressive Chinese herb medicine, in rats","volume":"30","author":"Shao","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.phrs.2020.105377_bib0200","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1081\/JLC-100101737","article-title":"Pharmacokinetics of triptolide. Development and application of a high performance liquid chromatographic method for quantitation of triptolide in plasma","volume":"22","author":"Mao","year":"1999","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.phrs.2020.105377_bib0205","first-page":"1049","article-title":"Nanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male rats","volume":"9","author":"Zhang","year":"2014","journal-title":"Int. J. Nanomed. Nanosurg."},{"key":"10.1016\/j.phrs.2020.105377_bib0210","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12951-018-0389-3","article-title":"Lipid nanoparticles loading triptolide for transdermal delivery: mechanisms of penetration enhancement and transport properties","volume":"16","author":"Gu","year":"2018","journal-title":"Int. J. Nanobiotechnology Pharm."},{"key":"10.1016\/j.phrs.2020.105377_bib0215","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.3109\/10717544.2015.1028603","article-title":"Pharmacokinetics and tissue distribution study in mice of triptolide-loaded lipid emulsion and accumulation effect on pancreas","volume":"23","author":"Li","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.phrs.2020.105377_bib0220","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpharm.2018.11.024","article-title":"Transdermal drug delivery of triptolide-loaded nanostructured lipid carriers: preparation, pharmacokinetic, and evaluation for rheumatoid arthritis","volume":"554","author":"Gu","year":"2019","journal-title":"Int J Pharmaceut"},{"key":"10.1016\/j.phrs.2020.105377_bib0225","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1556-276X-8-102","article-title":"Liposome: classification, preparation, and applications","volume":"8","author":"Akbarzadeh","year":"2013","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.phrs.2020.105377_bib0230","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3389\/fphar.2013.00143","article-title":"The use of lipid-based nanocarriers for targeted pain therapies","volume":"4","author":"Hua","year":"2013","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2020.105377_bib0235","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1517\/17425247.2.3.465","article-title":"Liposomes in the treatment of inflammatory disorders","volume":"2","author":"Metselaar","year":"2005","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.phrs.2020.105377_bib0240","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2014.0459","article-title":"Liposomes in tissue engineering and regenerative medicine","volume":"11","author":"Monteiro","year":"2014","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.phrs.2020.105377_bib0245","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jconrel.2015.06.017","article-title":"Development of target-specific liposomes for delivering small molecule drugs after reperfused myocardial infarction","volume":"220","author":"Dasa","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2020.105377_bib0250","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.nano.2014.11.003","article-title":"Liposome\u2013protein corona in a physiological environment: challenges and opportunities for targeted delivery of nanomedicines","volume":"11","author":"Caracciolo","year":"2015","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.phrs.2020.105377_bib0255","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/08982100903544144","article-title":"Preparation and anti-inflammatory activity of triptolide ethosomes in an erythema model","volume":"20","author":"Chen","year":"2010","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.phrs.2020.105377_bib0260","article-title":"Preparation of triptolide-liposome and its in vivo antitumor activity","volume":"4","author":"Xing-yao","year":"2007","journal-title":"Chin. J. Modern Appl. Pharm."},{"key":"10.1016\/j.phrs.2020.105377_bib0265","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.2147\/IJN.S141095","article-title":"Renal-targeted delivery of triptolide by entrapment in pegylated TRX-20-modified liposomes","volume":"12","author":"Yuan","year":"2017","journal-title":"Int. J. Nanomed. Nanosurg."},{"key":"10.1016\/j.phrs.2020.105377_bib0270","first-page":"1","article-title":"Pulmonary delivery of triptolide-loaded liposomes decorated with anti-carbonic anhydrase IX antibody for lung cancer therapy","volume":"7","author":"Lin","year":"2017","journal-title":"Sci Rep-Uk"},{"key":"10.1016\/j.phrs.2020.105377_bib0275","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/10717544.2018.1425777","article-title":"Dual-ligand modified liposomes provide effective local targeted delivery of lung-cancer drug by antibody and tumor lineage-homing cell-penetrating peptide","volume":"25","author":"Lin","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.phrs.2020.105377_bib0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118721","article-title":"Triptolide-loaded nanoparticles targeting breast cancer in vivo with reduced toxicity","volume":"572","author":"Zheng","year":"2019","journal-title":"Int J Pharmaceut"},{"key":"10.1016\/j.phrs.2020.105377_bib0285","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jconrel.2005.09.034","article-title":"Block copolymer micelles: preparation, characterization and application in drug delivery","volume":"109","author":"Gaucher","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2020.105377_bib0290","doi-asserted-by":"crossref","first-page":"17028","DOI":"10.1039\/C3RA47370H","article-title":"Polymeric micelles as drug delivery vehicles","volume":"4","author":"Ahmad","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.phrs.2020.105377_bib0295","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ijpharm.2015.01.009","article-title":"Paclitaxel-loaded micelles enhance transvascular permeability and retention of nanomedicines in tumors","volume":"479","author":"Danhier","year":"2015","journal-title":"Int. J. Pharmaceut."},{"key":"10.1016\/j.phrs.2020.105377_bib0300","first-page":"635","article-title":"Biodegradable polymeric micelles for drug delivery applications","volume":"Vol. 1","author":"B\u00f6lgen","year":"2018"},{"key":"10.1016\/j.phrs.2020.105377_bib0305","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.eurpolymj.2004.09.015","article-title":"Characterization and release of triptolide-loaded poly (D, L-lactic acid) nanoparticles","volume":"41","author":"Liu","year":"2005","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.phrs.2020.105377_bib0310","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jep.2004.10.031","article-title":"Anti-inflammatory effects of triptolide loaded poly (D, L-lactic acid) nanoparticles on adjuvant-induced arthritis in rats","volume":"97","author":"Liu","year":"2005","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2020.105377_bib0315","first-page":"188","article-title":"Preliminary research on abating rat testicle toxicity due to triptolide after oral polymer nanoparticle delivery","volume":"2","author":"Liu","year":"2008","journal-title":"Drug Discov. Ther."},{"key":"10.1016\/j.phrs.2020.105377_bib0320","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1166\/jnn.2008.136","article-title":"Effect of poly (D, L-lactic acid) nanoparticles as triptolide carrier on abating rats renal toxicity by NMR-based metabolic analysis","volume":"8","author":"Liu","year":"2008","journal-title":"J Nanosci Nanotechno"},{"key":"10.1016\/j.phrs.2020.105377_bib0325","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ejpb.2008.07.017","article-title":"Anti-tumour and immuno-modulation effects of triptolide-loaded polymeric micelles","volume":"70","author":"Xu","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.phrs.2020.105377_bib0330","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.tiv.2011.05.020","article-title":"Cytotoxicity of Triptolide and Triptolide loaded polymeric micelles in vitro","volume":"25","author":"Zheng","year":"2011","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.phrs.2020.105377_bib0335","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.fct.2013.03.044","article-title":"Acute and subacute toxicity studies on triptolide and triptolide-loaded polymeric micelles following intravenous administration in rodents","volume":"57","author":"Xu","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.phrs.2020.105377_bib0340","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1002\/adma.201200954","article-title":"Molecular engineered super\u2010nanodevices: smart and safe delivery of potent drugs into tumors","volume":"24","author":"Ding","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phrs.2020.105377_bib0345","doi-asserted-by":"crossref","first-page":"8027","DOI":"10.1021\/nn502074x","article-title":"pH-sensitive nanoformulated triptolide as a targeted therapeutic strategy for hepatocellular carcinoma","volume":"8","author":"Ling","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.phrs.2020.105377_bib0350","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1166\/jbn.2015.2016","article-title":"Inhibition of cancer angiogenesis using triptolide nanoparticles","volume":"11","author":"Wang","year":"2015","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.phrs.2020.105377_bib0355","first-page":"2663","article-title":"Fabrication of novel vesicles of triptolide for antirheumatoid activity with reduced toxicity in vitro and in vivo","volume":"11","author":"Zhang","year":"2016","journal-title":"Int. J. Nanomed. Nanosurg."},{"key":"10.1016\/j.phrs.2020.105377_bib0360","doi-asserted-by":"crossref","first-page":"8360","DOI":"10.18632\/oncotarget.7073","article-title":"Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2020.105377_bib0365","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.2147\/IJN.S151233","article-title":"Fabrication of a triptolide-loaded and poly-\u03b3-glutamic acid-based amphiphilic nanoparticle for the treatment of rheumatoid arthritis","volume":"13","author":"Zhang","year":"2018","journal-title":"Int. J. Nanomed. Nanosurg."},{"key":"10.1016\/j.phrs.2020.105377_bib0370","doi-asserted-by":"crossref","first-page":"7229","DOI":"10.2147\/IJN.S182197","article-title":"Ph-triggered charge-reversal and redox-sensitive drug-release polymer micelles codeliver doxorubicin and triptolide for prostate tumor therapy","volume":"13","author":"Xu","year":"2018","journal-title":"Int. J. Nanomed. Nanosurg."},{"key":"10.1016\/j.phrs.2020.105377_bib0375","doi-asserted-by":"crossref","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v16.i5.20","article-title":"Microemulsions: an overview and pharmaceutical applications","volume":"16","author":"Tenjarla","year":"1999","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.phrs.2020.105377_bib0380","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev-food-030216-025908","article-title":"Edible nanoemulsions as carriers of active ingredients: a review","volume":"8","author":"Salvia-Trujillo","year":"2017","journal-title":"Annu. Rev. Food Sci. Technol."},{"key":"10.1016\/j.phrs.2020.105377_bib0385","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jconrel.2004.06.001","article-title":"A study of microemulsion systems for transdermal delivery of triptolide","volume":"98","author":"Chen","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2020.105377_bib0390","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1016\/j.fct.2008.09.065","article-title":"In vivo evaluation of the safety of triptolide-loaded hydrogel-thickened microemulsion","volume":"46","author":"Xu","year":"2008","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.phrs.2020.105377_bib0395","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12951-017-0323-0","article-title":"Development of triptolide-nanoemulsion gels for percutaneous administration: physicochemical, transport, pharmacokinetic and pharmacodynamic characteristics","volume":"15","author":"Yang","year":"2017","journal-title":"Int. J. Nanobiotechnology Pharm."},{"key":"10.1016\/j.phrs.2020.105377_bib0400","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.2147\/IJN.S72593","article-title":"The potential of follicle-stimulating hormone peptide-modified triptolide-loaded nanoparticles to induce a mouse model of premature ovarian insufficiency","volume":"10","author":"Chen","year":"2015","journal-title":"Int. J. Nanomed. Nanosurg."},{"key":"10.1016\/j.phrs.2020.105377_bib0405","doi-asserted-by":"crossref","first-page":"11739","DOI":"10.1039\/C7NR03016A","article-title":"Triptolide and celastrol loaded silk fibroin nanoparticles show synergistic effect against human pancreatic cancer cells","volume":"9","author":"Ding","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.phrs.2020.105377_bib0410","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/adhm.201300034","article-title":"pH\u2010dependent anticancer drug release from silk nanoparticles","volume":"2","author":"Seib","year":"2013","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.phrs.2020.105377_bib0415","doi-asserted-by":"crossref","first-page":"12968","DOI":"10.1038\/s41598-018-29692-0","article-title":"Redox-responsive self-assembly PEG nanoparticle enhanced triptolide for efficient antitumor treatment","volume":"8","author":"Wang","year":"2018","journal-title":"Sci Rep-Uk"},{"key":"10.1016\/j.phrs.2020.105377_bib0420","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MCHD-0044-2016","article-title":"Glutathione and glutathione transferase omega 1 as key posttranslational regulators in macrophages","volume":"5","author":"Hughes","year":"2017","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.phrs.2020.105377_bib0425","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1080\/10717544.2019.1602796","article-title":"Cubic and hexagonal liquid crystals as drug carriers for the transdermal delivery of triptolide","volume":"26","author":"Shan","year":"2019","journal-title":"Drug Deliv."},{"key":"10.1016\/j.phrs.2020.105377_bib0430","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jconrel.2014.05.052","article-title":"Controlling molecular transport and sustained drug release in lipid-based liquid crystalline mesophases","volume":"188","author":"Zabara","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2020.105377_bib0435","doi-asserted-by":"crossref","first-page":"948","DOI":"10.2174\/1871520616666160926111911","article-title":"Polo-like kinase 1-targeting Chitosan Nanoparticles suppress the progression of hepatocellular carcinoma","volume":"17","author":"Wang","year":"2017","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"10.1016\/j.phrs.2020.105377_bib0440","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/10717544.2016.1264499","article-title":"In vitro and in vivo evaluation of macromolecular prodrug GC-FUA based nanoparticle for hepatocellular carcinoma chemotherapy","volume":"24","author":"Huang","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.phrs.2020.105377_bib0445","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.nano.2018.09.002","article-title":"Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms","volume":"15","author":"Zhang","year":"2019","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.phrs.2020.105377_bib0450","article-title":"Self-assembled casein nanoparticles loading triptolide for the enhancement of oral bioavailability","volume":"15","author":"Liu","year":"2020","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.phrs.2020.105377_bib0455","first-page":"560","article-title":"Synthesis, characterization, and evaluation of triptolide cell-penetrating peptide derivative for transdermal delivery of triptolide","volume":"15","author":"Tian","year":"2018","journal-title":"J. Mol. Pharm. Org. Process Res."},{"key":"10.1016\/j.phrs.2020.105377_bib0460","first-page":"1613","article-title":"Enhancing cellular uptake of activable cell-penetrating peptide\u2013doxorubicin conjugate by enzymatic cleavage","volume":"7","author":"Shi","year":"2012","journal-title":"Int. J. Nanomed. Nanosurg."},{"key":"10.1016\/j.phrs.2020.105377_bib0465","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijpharm.2013.01.059","article-title":"Premature drug release of polymeric micelles and its effects on tumor targeting","volume":"445","author":"Miller","year":"2013","journal-title":"Int. J. Pharmaceut."},{"key":"10.1016\/j.phrs.2020.105377_bib0470","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3390\/ijms17040561","article-title":"Linkers having a crucial role in antibody\u2013drug conjugates","volume":"17","author":"Lu","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2020.105377_bib0475","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.7150\/jca.16178","article-title":"Anti-cancer and sensibilisation effect of triptolide on human epithelial ovarian cancer","volume":"7","author":"Hu","year":"2016","journal-title":"J. Cancer"},{"key":"10.1016\/j.phrs.2020.105377_bib0480","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1053\/j.gastro.2010.04.046","article-title":"Triptolide induces cell death in pancreatic cancer cells by apoptotic and autophagic pathways","volume":"139","author":"Mujumdar","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2020.105377_bib0485","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.canlet.2014.03.016","article-title":"Triptolide sensitizes pancreatic cancer cells to TRAIL-induced activation of the death receptor pathway","volume":"348","author":"Chen","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2020.105377_bib0490","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12906-019-2616-3","article-title":"Triptolide attenuates lipopolysaccharide-induced inflammatory responses in human endothelial cells: involvement of NF-\u03baB pathway","volume":"19","author":"Song","year":"2019","journal-title":"BMC Complement. Altern. Med."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820316856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820316856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:15:54Z","timestamp":1760912154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661820316856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":98,"alternative-id":["S1043661820316856"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2020.105377","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triptolide delivery: Nanotechnology-based carrier systems to enhance efficacy and limit toxicity","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2020.105377","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105377"}}